title: [The characteristics of absorption in the small intestine of young infants with hypotrophy and encephalopathy undergoing protein-anabolic therapy].
abstract: The small intestinal absorption was comparatively studied in 49 patients with hypotrophy and encephalopathy (the test with D-xylose): 25 of them received balanced artificial feeding (control group), while 24 patients were also given protein enteral feeding formula [correction of enpit] and retabolil. Absorption disorders were revealed mainly in the proximal portion of the intestine, and its improvement under the influence of the protein-anabolic therapy was recorded. D-xylose renal excretion during 5 h in the treated patients was by 14.3% higher as compared to those in the control group, and it reached the standard level in the normal children (34.4 +/- 3.2%). Daily average increase of the body mass in patients who received the protein anabolic therapy was twofold higher than that in the children of the control group.
authors.forename: N I
authors.initials: NI
authors.lastname: Aleksandrova
authors.forename: S B
authors.initials: SB
authors.lastname: Khatskel'
authors.forename: L M
authors.initials: LM
authors.lastname: Lavut
mesh_terms: D045930:Anabolic Agents / Q000008:administration & dosage*; D001927:Brain Diseases / Q000503:physiopathology* / Q000628:therapy; D004044:Dietary Proteins / Q000008:administration & dosage*; D005183:Failure to Thrive / Q000503:physiopathology* / Q000628:therapy; D005243:Feces / Q000032:analysis; D006801:Humans; D007223:Infant; D007225:Infant Food; D007408:Intestinal Absorption / Q000502:physiology*; D007421:Intestine, Small / Q000503:physiopathology*; D009277:Nandrolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077603:Nandrolone Decanoate; D013997:Time Factors; D014994:Xylose / Q000032:analysis
chemical_list: D045930:Anabolic Agents; D004044:Dietary Proteins; D009277:Nandrolone; D014994:Xylose; D000077603:Nandrolone Decanoate
vernacular_title: Osobennosti vsasyvaniia v tonkoĭ kishke u deteĭ rannego vozrasta s gipotrofieĭ i éntsefalopatieĭ pri belkovo-anabolicheskoĭ terapii.